期刊文献+

1例肝硬化合并肾功能不全患者利奈唑胺剂量调整的药学监护

Pharmaceutical care and dose adjustment of linezolid in a patient with liver cirrhosis and renal insufficiency
原文传递
导出
摘要 报道1例利奈唑胺致肝硬化合并肾功能不全患者血小板减少的病例。患者为老年男性,以“院外治疗后腹痛、腹胀加剧”为主诉入院。临床药师结合患者实际情况,建议经验给予亚胺培南西司他丁(1 g,iv gtt,q8h)联合利奈唑胺(0.6 g,iv gtt,q12h)抗感染治疗,并对利奈唑胺进行血药浓度监测。治疗过程中患者利奈唑胺谷浓度异常偏高且出现血小板减少,考虑为利奈唑胺所致不良反应,停用利奈唑胺并对症处理后血小板回升。因临床需要,在血药浓度监测下再次启用利奈唑胺(0.2 g,iv gtt,q12h)抗感染治疗,治疗后患者感染得到了有效控制,且未再出现血小板减少。
出处 《中国临床药学杂志》 CAS 2022年第8期628-630,共3页 Chinese Journal of Clinical Pharmacy
基金 常德市科学技术局项目(编号2019S180)
  • 相关文献

参考文献3

二级参考文献30

  • 1MOELLERING RC. Linezolid: the first oxazolidinone antimi- crobial[J]. Ann Intern Med, 2003, 138(2) : 135-142.
  • 2MCGOWAN AP. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram positive infections[J]. J Antimicrob Chemother, 2003, 51 Suppl 2: ii17- ii25.
  • 3STALKER DJ, JUNGBLUTH GL, HOPKINS NK, et al. Pharmacokinetics and tolerance of single and multiple dose oral or intravenous linezolid, and oxazolidinone antibiotic, in healthy colunteers[J]. J Antimicrob Chemother, 2003, 51 (5): 1239- 1246.
  • 4PEA F, SCUDELLER L, LUGANO M, et O1. Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient[J]. Clin Infect Dis, 2006, 42(3): 433-434.
  • 5APODACA AA, RAKITA RM. Linezolid-indueed lactic acidosis [J]. N Engl J Med, 2003, 348 (1) : 86-87.
  • 6KOPTERIDES P, PAPADOMICHELAKIS E, ARMAGANIDIS A. Linezolid use associated with lactic acidosis[J]. Scand J Infect Dis, 2005, 37(2): 153-154.
  • 7PALENZUELA L, HAHN NM, NELSON RP Jr, et ol. Doeslinezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis?[J]. Clin Infect Dis, 2005, 40(12): el13-el16.
  • 8SWOBODA S, OBER MC, LICHTENSTERN C, et al. Pharmacokinetics of linezolid in septic patients with and without extended dialysis[J]. Eur J Clin Pharmacol, 2010, 66(3): 291- 298.
  • 9RADUNZ S, JUNTERMANNS B, KAISER GM, et ol. Efficacy and safety of linezolid in liver transplant patients [J]. Transpl Infect Dis, 2011, 13(4) : 353-358.
  • 10TAKAHASHI Y, TAKESUE Y, NAKAJIMA K, eta!. Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy[J]. J Infect Chemother, 2011, 17(3): 382-387.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部